原著

1. Hashimoto K, Yokokawa T, Nonomiya Y, Shibata N, Soejima A, Kobayashi K, Mae Y, Hasegawa A, Aoyama T, Tateai Y, Ban S, Nigata K, Abe R, Kawakami K, Shimizu H, Ariyasu R, Yanagitani N, Hasegawa K, Kawaguchi T, Yamaguchi M, Suzuki K.
   Age-Stratified Risk of Carboplatin-Induced Nausea and Vomiting in Lung Cancer Patients.
   Oncology 2025, 10:1-12.　doi: 10.1159/000544875.

総説

著書

1. 横川貴志（編集）　メジカルビュー社　『がん専門薬剤師の極意を学ぶ！ 症状アセスメント実践ゼミ』

その他

原著

1. Hatori M, Tsuji D, Suzuki K, Yokokawa T, Kawakami K, Moriyama R, Osada-Tsuchiya M, Otake A, Nakao M, Yano T, et al: 
   Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study). 
   Cancer 2024, 130:2988-2999.　doi: 10.1002/cncr.35343.
    
2. Iwasaki Y, Hiraide M, Taguchi H, Iehisa R, Akiyama H, Suzuki K, Shimizu H, Yamaguchi M: 
   Removal efficiency of antineoplastic drug cyclophosphamide by hypochlorous acid. 
   J Occup Environ Hyg 2024:1-9.　doi.org/10.1080/15459624.2024.2423752
    
3. Suzuki K, Yokokawa T, Kawaguchi T, Takada S, Tamaki S, Kawasaki Y, Yamaguchi T, Koizumi K, Matsumoto T, Sakata Y, et al: 
   A multicenter, phase II trial of triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for highly emetogenic chemotherapy in breast cancer (PATROL-II). 
   Sci Rep 2024,14:28271.　doi: 10.1038/s41598-024-79781-6.
    
4. Honma T, Onda K, Masuyama K.
   Progressive Multifocal Leukoencephalopathy Reports in Rheumatoid Arthritis Concerning Different Treatment Patterns-an Exploratory Assessment Using the Food and Drug Administration Adverse Event Reporting System 
   Front. Drug Saf. Regul 2024 doi: 10.3389/fdsfr.2024.1334468.
    
5. Tomomatsu T, Shimizu H, Yokokawa T, Fukada I, Kawakami K, Kobayashi K, Aoyama T, Suzuki W, Sugisaki　T, Hashimoto K, Asano M, Mori Y, Hara F, Takano T, Ohno S, Yamaguchi M
   Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study. 
   Yakugaku zassh 2024, 144:897-904.　DOI: 10.1248/yakushi.24-00030　PMID: 39218657
    
6. Yoshida N, Imai S, Kawakami K, Yokokawa T, Nakamura M, Aoyama T, Shimizu H, Naito R, Teramae M,Tsuchiya M, Kizaki H, Ozaka M, Sasahira N, Yamaguchi M, Hori S, Factors Affecting Delayed Recovery from Neutropenia in Patients with Pancreatic Cancer Receiving Gemcitabine plus Nab-Paclitaxel. 
   JCancer 2025, 16:1413-1419.　DOI: 10.7150/jca.107359　
    
7. 浅野舞美，清水久範，横川貴志，鈴木亘，川上和宜，小林一男，杉﨑崇人，青山剛，式部さあ里, 友松拓哉，深田一平，高野利実，山口正和: 
   乳癌周術期FEC療法におけるペグフィルグラスチム使用による血球成分の推移調査. 
   癌と化学療法 2024, 51:913-918.　PMID: 39462626

総説

1. 恩田 健二 
   妊娠高血圧腎症における抗酸化ストレス分子を標的とした既存薬の橋渡し研究
   Yakugaku Zasshi 2025 145(1)43-47 　doi.org/10.1248/yakushi.24-00174-1
    

著書

1. 鈴木賢一（共著）横川貴志（共著）　医学書院　『がん薬剤師外来マニュアル』
2. 横川貴志（共著）　医学書院　『がん薬物療法副作用管理マニュアル第3版』
3. 横川貴志（共著）　医学書院　『がん薬物療法のひきだし 第2版: 腫瘍薬学の基本から応用まで』

その他

1. 恩田健二
   大学での大規模医療データの利活用　～臨床•基礎研究、教育をつなぐ架け橋として～
   JAPIC NEWS　2025年3月号（No.490）

原著

1. Honma T, Onda K, Masuyama K.
   Drug-drug Interaction Assessment Based on a Large-scale Spontaneous Reporting System for Hepato- and Renal-toxicity, and Thrombocytopenia with Concomitant Low-dose Methotrexate and Analgesics Use
   BMC Pharmacol Toxicol 2024 1;25(1):13. doi: 10.1186/s40360-024-00738-6.
2. Kusakawa, Kashiwagi , Abe Y, Tsusaka S ,Sugiyama K, Sawada A, Kawashima H
   Significance of 25-hydroxy vitamin D in early infants infected with respiratory syncytial virus
   J. Tokyo Med. Univ., 80（3）: 189-201, 2022
3. Wakui N, Kikuchi M, Ebizuka R, Yanagiya T, Togawa C, Matsuoka R, Ikarashi N, Yamamura M, Shirozu S, Machida Y, Suzuki K, Kato H. 
   Survey of Pharmacists' Knowledge, Attitudes, and Practices (KAP) concerning COVID-19 Infection Control after Being Involved in Vaccine Preparation: A Cross-Sectional Study. 
   Int J Environ Res Public Health. 2022 Jul 25;19(15):9035. doi: 10.3390/ijerph19159035.
4. Azechi T, Sasano H, Sato K, Arakawa R, Suzuki K. 
   Evaluation of Knowledge Regarding the Use of Antibiotics among Pharmacy Undergraduates in Japan. J Microbiol Biol Educ. 2022 Nov 14;23(3):e00146-22. doi: 10.1128/jmbe.00146-22.
5. Ichimura T, Ogawa C, Murata H, Miyahara K, Yuge S, Tsukioka R, Kado K, Yoshimura T, Suzuki K, Nomura H, Shimizu H. 
   Community pharmacists' measurement of health-related quality of life in outpatients taking high-risk drugs. 
   Pharmazie. 2022 Jun 1;77(6):202-206. doi: 10.1691/ph.2022.1914.
6. Wakui N, Noguchi N, Ichikawa K, Togawa C, Matsuoka R, Yoshizawa Y, Shirozu S, Suzuki K, Ozawa M, Yanagiya T, Kikuchi M. 
   Psychological and Physical Changes Caused by COVID-19 Pandemic in Elementary and Junior High School Teachers: A Cross-Sectional Study. 
   Int J Environ Res Public Health. 2022 Jun 21;19(13):7568. doi: 10.3390/ijerph19137568.
7. Aoyama T, Nakano K, Yuasa T, Sugiyama E, Okawa T, Ito K, Azuma K, Hashimoto K, Furutani R, Hiraide M, Kobayashi K, Suzuki K, Tomomatsu J, Tajima M, Sato H, Hama T, Takahashi S. 
   Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma. Sci Rep. 2023 Feb 6;13(1):2099. doi: 10.1038/s41598-023-28688-9.
8. Suzuki K. [Education Aimed at Patient Safety Management of Chemotherapy Conducted at University Education Sites]. 
   Yakugaku Zasshi. 2023;143(3):213-216. Japanese. doi: 10.1248/yakushi.22-00160-1. 
   2024
9. Yamazaki K, Kiyomi A, Imai S, Sugiyama K, Tahara K, Sawada T, Sugiura M. 
   Effect of prednisolone and saireito co-administration on T-cells of rheumatoid arthritis patients. 
   Clin Exp Rheumatol. 2023 Sep;41(9):1777-1783. doi: 10.55563/clinexprheumatol/ohcf0k.
10. 木村 優花  , 川上 和宜, 中村 匡志, 横川 貴志, 清水 久範, 小林 一男, 青山 剛, 鈴木 亘, 羽鳥 正浩, 鈴木 賢一, 高張 大亮, 小倉 真理子, 陳 勁松, 中山 厳馬, 若槻 尊, 山口 研成, 山口 正和
    胃がん術後CAPOX療法におけるカペシタビンの残薬評価
    Yakugaku  Zasshi 2023 年 143 巻 12 号 p. 1075-1081 DOI https://doi.org/10.1248/yakushi.23-00124
11. Abe M, Yamaguchi T, Fujita Y, Nishimura T, Kitagawa K, Inui N, Hirano K, Sakata Y, Iihara H, Shibuya Y, Suzuki K, Shibata K, Hori K, Daga H, Nakayama T, Sakata Y, Takahashi TY, Zenda S, Hashimoto H. 
    Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial. 
    JAMA Netw Open. 2023 May 1;6(5):e2310894. doi: 10.1001/jamanetworkopen.2023.10894.
12. 畦地 拓哉, 齊藤 有希, 小柴 聖史, 鈴木 賢一,
    がん患者とがん化学療法に関わる薬剤師に対する薬学生のイメージ, 
    薬学教育, 2023, 7 doi.org/10.24489/jjphe.2022-049,
13. Yokokawa T, Suzuki K, Tsuji D, Hosonaga M, Kobayashi K, Kawakami K, Kawazoe H, Nakamura T, Suzuki W, Sugisaki T, Aoyama T, Hashimoto K, Hatori M, Tomomatsu T, Inoue A, Azuma K, Asano M, Takano T, Ohno S, Yamaguchi M. 
    Influence of menopause on chemotherapy-induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study. 
    Cancer Med. 2023 Sep;12(18):18745-18754. doi: 10.1002/cam4.6494.
14. Tsuji D, Nakagaki S, Yonezawa I, Suzuki K, Yokokawa T, Kawasaki Y, Yamaguchi T, Kawaguchi T, Hatori M, Matsumoto T, Sakata Y, Yamamoto K, Nishimura T, Kogure Y, Hayashi T, Osawa M, Itoh K, Watanabe M. 
    A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I. 
    Invest New Drugs. 2024 Feb;42(1):44-52. doi: 10.1007/s10637-023-01414-y. 

原著

1. Onda K, Honma T, Masuyama K.
   Methotrexate-related Adverse Events and Impact of Concomitant Treatment with Folic Acid and Tumor Necrosis Factor-alpha Inhibitors: An Assessment Using the FDA Adverse Event Reporting System.
   Front. Pharmacol. 14:1030832.  2023 doi.org/10.3389/fphar.2023.1030832
   (本誌 Research Topicの特集欄（Pharmacovigilance and Drug Repositioning Research using Pharmacoepidemiology）に採択されました。)
    
2. De Alwis N, Fato BR, Beard S, Binder NK, Kaitu'u-Lino TJ, Onda K, Hannan NJ.
   Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease.
   Int J Mol Sci. 2022 Aug 23;23(17):9533. doi: 10.3390/ijms23179533.
    
3. Kusakawa G, Kashiwagi Y, Yuka A, Tsusaka S, Sugiyama K, Sawada A, Kawashima H. 
   Significance of 25-hydroxy vitamin D in early infants infected with respiratory syncytial virus. 
   Journal of Tokyo Medical University. 80(3) 189-201 2022
    
4. Yamazaki K, Anna Kiyomi, Imai S, Sugiyama K, Tahara K, Sawada T, Sugiura M. 
   Effect of prednisolone and saireito coadministration on T-cells of rheumatoid arthritis patients.
   Clin Exp Rheumatol. in press 2022年

邦文

1. 杉山健太郎, 木下葉月, 丸山晃典, 前田真奈 薬学生のドナーコーディネーターに対する認知度調査について 日本臨床腎移植学会雑誌（メディカルスタッフ優秀賞受賞論文）10(2) 269-273 2022

原著

1. Azuma K, Kawaguchi T, Yamaguchi T, Motegi S, Yamada K, Onda K, Iwase S, Unezaki S, Takeuchi H. Development of Japanese Versions of the Control Preferences Scale and Information Needs Questionnaire: Role of Decision-Making and Information Needs for Japanese Breast Cancer Patients. Patient Prefer Adherence. 2021;15:1017-1026
   https://doi.org/10.2147/PPA.S295383
2. Xu W, Wu H, Tahara K, Chen S, Wang X, Tanaka S, Sugiyama K, Sawada T, Hirano T. Effects of vitamin K2 combined with methotrexate against mitogen‐activated peripheral blood mononuclear cells of healthy subjects and rheumatoid arthritis patients.  Fundamental & Clinical Pharmacology 35: 832-842 2021 doi.org/10.1111/fcp.12676
3. Okihara M, Takeuchi H, Akiyama S, Yoshinaga S, Osato S, Akashi I, Kihara, Y, Iwamoto H, Oda T, Tanaka S, Unezaki S, Hirano T.  Pharmacodynamic drug-  drug interaction on human peripheral blood mononuclear cells between everolimus and tacrolimus at the therapeutic concentration range in renal transplantation.  Annals Transplant. 2021 in press
4. Xu W, Chen S, Wang X, Tahara K, Wu H, Tanaka S, Sugiyama K, Sawada T, Hirano T.Suppressive effect of vitamin K2 against mitogen-activated peripheral blood mononuclear cells of rheumatoid arthritis patients. Int J Clin Pharmacol Ther. 59: 55 - 62 2021 doi.10.5414/cp203827
5. Meiyu Zhang, Taro Miura, Shunsuke Suzuki, Masako Chiyotanda, Sachiko Tanaka, Kentaro Sugiyama, Hisashi Kawashima, Toshihiko Hirano. Vitamin K2 Suppresses Proliferation and Inflammatory Cytokine Production in Mitogen-Activated Lymphocytes of Atopic Dermatitis Patients through the Inhibition of Mitogen-Activated Protein Kinases. Biological and Pharmaceutical Bulletin 44(1) 7 - 17 2021 doi.org/10.1248/bpb.b20-00079
6. Xu Wencheng, Kusano J, Chen S, Yamamoto R, Matsuda H, Hara Y, Fujii Y, Hayashi S, Tanaka S, Sugiyama K, Yamada H, Hirano T.Absolute configuration of tetrandrine and isotetrandrine influences their anti-proliferation effects in human T cells via different regulation of NF-κB  Zeitschrift für Naturforschung C. 2021 76(1-2)c: 21-25 DOI 10.1515/znc-2020-0064
7. Xu W, Chen S, Wang X, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T. Molecular mechanisms and therapeutic implications of tetrandrine and cepharanthine in T cell acute lymphoblastic leukemia and autoimmune diseases. Pharmacology & Therapeutics 217 107659 - 107659 2021 doi.org/10.1016/j.pharmthera.2020.107659
8. Wencheng Xu, Hongguang Wu, Koichiro Tahara, Shuhe Chen, Xiaoqin Wang, Sachiko Tanaka, Kentaro Sugiyama, Tetsuji Sawada, Toshihiko Hirano. Effects of vitamin K2 combined with methotrexate against mitogen-activated peripheral blood mononuclear cells of healthy subjects and rheumatoid arthritis patients. Fundamental & Clinical Pharmacology 2021 in press
9. Wencheng Xu, Shuhe Chen, Xiaoqin Wang, Hongguang Wu, Koichiro Tahara, Sachiko Tanaka, Kentaro Sugiyama, Haruki Yamada, Tetsuji Sawada, Toshihiko Hirano. Effects of sinomenine on the proliferation, cytokine production, and regulatory T‐cell frequency in peripheral blood mononuclear cells of rheumatoid arthritis patients  Drug Development Research 82(2) 251 - 258 2021 doi.org/10.1002/ddr.21748

邦文

1. 本間丈士, 亀山俊, 前田正輝, 堀口雅巳, 平野俊彦, 杉山健太郎　病院薬剤師と薬局薬剤師を対象とした関節リウマチ治療に関する意識調査 　応用薬理 101(1/2) 7-14 2021

原著

1. Kanazawa H, Obara H, Yoshikawa R, Meng L, Hirano T, Okada Y, Nishikawa Y, Matsuno N. Impact of machine perfusion on sinusoid microcirculation of liver graft donated after cardiac death. J Surg Res 254:410-419; 2020

2. Endo M, Hirano R, Shibasaki H, Yokokawa A, Furuta T, Abe K, Morita K, Tanaka S, Hirano T, Sakurai M, Mizuno K. Midazolam intoxication in a premature neonate. Clin Ther. 2020 in press

3. Xu W, Wu H, Chen S, Wang X, Tanaka S, Sugiyama K, Yamada H, Hirano T. Cytotoxic effects of vitamins K1, K2 and K3 against human T lymphoblastoid leukemia cells through apoptosis induction and cell cycle arrest. Chem Biol Drug Des. 96(4) 1134 - 1147 2020 doi 10.1111/cbdd.13696

4. Wencheng Xu, Xiaoqin Wang, Shuhe Chen, Hongguang Wu, Sachiko Tanaka, Kenji Onda, Kentaro Sugiyama, Haruki Yamada, Toshihiko Hirano. Tetrandrine enhances glucocorticoid receptor translocation possibly via inhibition of P-glycoprotein in daunorubicin-resistant human T lymphoblastoid leukemia cellsEuropean Journal of Pharmacology 881 173232 - 173232 2020

5. Xu W, Chen S, Wang X, Wu H, Yamada H, Hirano T. Bisbenzylisoquinoline alkaloids and P-glycoprotein function: A structure activity relationship study. Bioorg Med Chem, 28:115553; 2020.

6. Xu Wencheng, Kusano J, Chen S, Yamamoto R, Matsuda H, Hara Y, Fujii Y, Hayashi S, Tanaka S, Sugiyama K, Yamada H, Hirano T.Absolute configuration of tetrandrine and isotetrandrine influences their anti-proliferation effects in human T cells via different regulation of NF-κB 
   Zeitschrift für Naturforschung C.  76(1-2) 21 - 25 2021 DOI 10.1515/znc-2020-0064

7. Yu B, Yuan B, Li JZ, Kiyomi A, Kikuchi H, Hayashi H, Hu X, Okazaki M, Sugiura M, HirYu B, Yuan B, Li JZ, Kiyomi A, Kikuchi H, Hayashi H, Hu X, Okazaki M, Sugiura M, Hirano T, Fan Y, Pei X, Takagi N. JNK and autophagy independently contributed to cytotoxicity of arsenite combined with tetrandrine via modulating cell cycle progression in human breast cancer cells. Frontiers in Pharmacology. 2020 in press

8. Endo M, Hirano R, Shibasaki H, Yokokawa A, Furuta T, Abe K, Morita K, Tanaka S, Hirano T, Sakurai M, Mizuno K. Midazolam Intoxication in a Premature Neonate. Case Reports Clin Ther  2020, 42(5):946-951.

9. Honma T, Onodera D, Horiguchi M, Sugiyama K, Hirano T. Influence of folic acid on suppressive efficacy of methotrexate against mitogen-activated human peripheral-blood mononuclear cells. Curr Top Pharmacol. 2020, 24: 49-60.

10. Xu W, Chen S, Wang X, Kusano J, Yamamoto R, Matsuda H, Hara Y, Fujii Y, Hayashi S, Tanaka S, Sugiyama K, Yamada H Hirano T. NF-κB regulation by bisbenzylisoquinoline alkaloids in human T cells : A structure-activity relationship study. Med Chem Res.  2020, 29(12):2123–2129. doi.org/10.1007/s00044-020-02624-2

11. Xu W, Yamada H, Hirano T. Methylprednisolone potentiates tetrandrine pharmacodynamics against human T lymphoblastoid leukemia MOLT-4 cells via regulation of NF-κB activation and cell cycle transition.  Steroids 2020 in press

12. Xu W, Chen S, 4, Wang X, Wu H, Tahara K, Tanaka S, Sugiyama K, Yamada H, Sawada T, Hirano T. Effects of sinomenine on the proliferation, cytokineproduction and regulatory T-cell frequency in peripheralblood mononuclear cells of rheumatoid arthritis patients. Chem Biol Drug Des. 2020;96:1133–1146. doi 10.1002/ddr.21748

13. Kiyomi A, Miyakawa R, Matsumoto J, Yamazaki K, Imai S, Yuan B, Hirano T, Sugiura M.  Potent antitumor activity of cepharanthine against triple‑negative breast cancer spheroids compared with tetrandrine.  Oncology Letters 20: 331: 2020, doi 10.3892/ol.2020.12191

和文

　　　袁　博、岡崎真理、平野俊彦　ヒ素化合物の抗腫瘍活性およびその新規臨床応用の可能性　ファルマシア　56(5),421-425, 2020.

原著

1. Sugiyama K, Wada S, Tanaka S, Urai K, Hirano T.
   Effects of the tooth-coating solution and its components on the proliferation and production of inflammatory cytokines in mitogen-activated human peripheral blood mononuclear cells. 
   Curr Top Pharmacol. 23: 93-101 2019
    

2. Xu W, Wang X, Tu Y, Masaki H, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T.
   Tetrandrine and cepharanthine induce apoptosis through caspase cascade regulation, cell cycle arrest, MAPK activation and PI3K/Akt/mTOR signal modification in glucocorticoid resistant human leukemia Jurkat T cells.
   Chem Biol Interact 2019 310:108726. doi: 10.1016/j.cbi.2019.108726.  

3. Pan C, Onda K, Hirano T.
   Bevacizumab versus Anti-preeclamptic Drugs: Evaluation with Three-dimensionally Co-cultured Human Mini Tumors. 
   Anticancer Res. 2019 39: 3543-3551. doi: 10.21873/anticanres.13500

4. Zhao Y, Tanaka S, Yuan B, Sugiyama K, Onda K, Kiyomi A, Takagi N, Sugiura S, Hirano T.
   Arsenic disulfide combined with L-buthionine-(S, R)-sulfoximine induces synergistic antitumor effects in two-dimensional and three-dimensional models of MCF-7 breast carcinoma cells.
   Am J Chinese Med. 47(5): 1149-1170  2019

5. Xu W, Wang X, Tu Y, Masaki H, Tanaka S, Onda K, Sugiyama K, Yamada H, Hirano T.
   Plant-derived alkaloid sinomenine potentiates glucocorticoid pharmacodynamics in mitogen-activated human peripheral blood mononuclear cells by regulating the translocation of glucocorticoid receptor.
   Phytother Res. 33(1): 187-196 2019

6. Zhao Y, Onda K, Sugiyama K, Yuan B, Tanaka S, Takagi N, Hirano T.
   Antitumor effects of arsenic disulfide on the viability, migratory ability, apoptosis and autophagy of breast cancer cells.
   Oncol Rep. 41(1): 27-42 2019

7. Obara H, Morito N, Matsuno N, Yoshikawa R, Nakajo T, Gochi M, Otani M, Shonaka T, Furukawa H, Hirano T, Enosawa S.  
   Initial perfusate purification during subnormothermic machine perfusion for porcine liver donated after cardiac death. J Artif Organs. 23: 62–69 2020

8. Xu W, Meng K, Wu H, Miura T, Suzuki S, Chiyotanda M, Tanaka S, Sugiyama K, Kawashima H, Hirano T.
   Vitamin K2 immunosuppressive effect on pediatric patients with atopic dermatitis.
   Pediatr Int. 61: 1188-1195 2019

9. Bowen Yu, Bo Yuan, Anna Kiyomi, Hidetomo Kikuchi, Hideki Hayashi, Xiaomei Hu, Mari Okazaki, Munetoshi Sugiura, Toshihiko Hirano, Xiaohua Pei, Norio Takagi
   Differentiation induction of human breast cancer cells by arsenite in combination with tetrandrine.
   American Journal of Translational Research 2019 in press  11(12):7310-7323 2019.

和文

     1. 杉山健太郎、平野俊彦　臓器提供に関する薬学生の生前家族協議アンケート調査について　
          日本臨床腎移植学会雑誌 7(2) 156-160：2019

著書

1. 袁博，清海杏奈，平野俊彦　ヒ素化合物とテトランドリン併用の乳癌治療応用への可能性　
   メディカル・サイエンス・ダイジェスト　ニューサイエンス社　45(8) 424-426：2019

総説

　  1. 小原弘道、吉川 遼、松野直徒、中條哲也、絵野沢伸、平野俊彦　
         機械潅流が可能にする代謝に着目した移植のための臓器機能評価技術
         Organ Biology 26(2):123-128：2019